Matthew Napier

Matthew Napier

Economist

Matthew joined in November 2022 after graduating from the University of Birmingham with a distinction in MSc Health Economics and Health Policy. His dissertation was written during an internship and involved an early cost-effectiveness model in sickle cell disease for an early pipeline asset.